Target intelligence / Profile preview

Coagulase (N/A)

Target: N/A
Molecular classification: Enzyme, Hydrolase

Overview

Coagulase is an enzyme produced by Staphylococcus aureus that converts fibrinogen in plasma to fibrin. This process leads to the formation of a fibrin clot around the bacterial cells, protecting them from phagocytosis and other host defenses. Coagulase production is a key virulence factor and diagnostic marker for S. aureus.

Mechanism of action

Coagulase converts fibrinogen to fibrin, leading to the formation of a fibrin clot. Inhibitors of coagulase prevent this conversion, thereby disrupting bacterial immune evasion and biofilm formation.

Biological functions

Fibrin clot formationImmune evasion

Disease associations

InfectionBacterial pathogenesis

Safety considerations

Potential for off-target effects on host coagulation pathways.

Beyond the preview

Go deeper on Coagulase (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coagulase (N/A).

Explore the full profile